GC021109 for Mild to Moderate Alzheimer's Disease
Language
Undefined
Purpose: To test the safety and pharmacokinetics of the experimental drug GC021109 in people with mild to moderate Alzheimer's disease.
Source: Alzheimers Clinical Trials - Category: Geriatrics Authors: chirschman Source Type: clinical trials